Social media is here to stay, and its use must be a consideration in the treatment of psychiatric conditions, particularly substance use disorder and alcohol use disorder.
A diverse group of psychiatrists elaborates on the difficult conversation surrounding reparations, and why our society needs to pay attention.
Often misdiagnosed as other psychiatric disorders, FTD is the third most common type of dementia and the second most common among patients 65 years or younger. How to spot the signs.
“I have found that community involvement is really key to a sense of belonging and really feeding our soul as we think about maintaining our mental health.”
"CT-R emphasizes the importance of hope while taking it a step further, turning hope into meaningful action and internalizing what success says about a person’s identity, strength, and ability to navigate future challenges."
The LGBTQIA+ community has faced marginalization and stereotyping in media, including video games. Let’s examine the intersection of identity, mental health, and video gaming.
What are the challenges and opportunities for improvement in COVID-19-related mental health care?
Clinicians wrap up their discussion on novel, rapid-acting agents for major depressive disorder (MDD) with key insights and takeaways for providers.
Instead of figuring out ways to help people die, what if we devoted our energy to helping them live, even and especially if they are dying?
How can a robust understanding of the altered-state experience drive the development of therapeutic frameworks that are designed around that experience?
The key to addressing mental health may lie in business innovation theories.
A phase 2A trial recently received confirmation to proceed in investigating psilocybin-assisted psychotherapy in the treatment of adult patients with IBS.
How can Ibogaine help patients with Alcohol Use Disorder, specifically in veterans?
In this CME article, learn more about the best practices for engaging patients in the informed consent process for psychedelic treatment and psychedelic-assisted psychotherapy.
COVID-19 has made treating patients who receive long-acting injectables complicated. The Chief Medical Officer of Houston Behavioral Healthcare Hospital offers suggestions on how best to proceed.
Psychiatric disorders affect 1 in 3 individuals with epilepsy—and their etiology is multifactorial.
In this CME article, review literature on SRI-related bleeding complications in patients with GI bleeding, malignancy, perioperative settings, pregnancy, and hormonal therapy.
In this CME article, learn more about how to assess the impact of alcohol and cannabis use on anxiety treatment outcomes, recognizing potential adverse effects and interactions.
Tips for helping patients preserve their sobriety through the holiday season
Why does the prospect of getting back to normal after the pandemic disturb some patients? And what can be done to overcome these fears?
Violence against women and resulting traumatic brain injuries increased during the COVID-19 pandemic.
How can you best address and support transgender patients, as well as prevent negative outcomes?
Here's everything you need to know about about the 2024 APA Annual Meeting and how to prep for next year's meeting, from members of the Scientific Program Committee.
In older adults with bipolar disorder, what evidence is there to guide treatment?
Which innovations can improve measurement, technology, investment, and public policy surrounding brain health?
How can you as clinicians balance a patient’s right to autonomy with beneficence?
Here's everything you need to know about about the 2024 APA Annual Meeting and how to prep for next year's meeting, from members of the Scientific Program Committee.
In this CME, review the risks and clinical implications of intimate partner violence on women’s substance use and treatment.